Amit Kumar completed a Master’s degree in Biotechnology and obtained his Ph.D. in Stem cells and Neurodegenerative diseases from National Institute of Immunology, New Delhi, India. During his Ph.D. research, he worked extensively on differentiation of mesenchymal stem cells and neural stem cells into dopaminergic neuron-like cells, in an effort to develop novel therapeutic approaches to Parkinson’s disease. I also worked on hematopoietic stem cells into hepatocytes and interested to study the regulation of hematopoiesis and cancer by the niche cells. I also got an opportunity to study the regulation of myogenesis during embryonic development as a Postdoctoral scholar.
In the Rao lab, my focus is to understand the regulation of leukemogenesis and hematopoiesis by RNA binding proteins. The anticipated outcome of the study potentially help to develop drug targets of therapeutic relevance. At the same time, I am also involved in long non-coding RNAs (lncRNAs) to study their mechanism in developing drug resistance/sensitivity in B-ALL.